Upgrades/Downgrades
Updated: 01-Sep-26 09:45 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Timken | TKR | BofA Securities | Neutral » Buy | $135 | |
| Tidewater | TDW | BTIG Research | Neutral » Buy | $120 | |
| Tempus AI | TEM | Piper Sandler | Neutral » Overweight | $76 | |
| TC Energy | TRP | Jefferies | Hold » Buy | ||
| Sempra Energy | SRE | Jefferies | Hold » Buy | $97 | |
| Park Hotels & Resorts | PK | BMO Capital Markets | Market Perform » Outperform | $18 | |
| Nuveen Churchill Direct Lending Corp. | NCDL | UBS | Neutral » Buy | $13 | |
| Lloyds Banking | LYG | BofA Securities | Neutral » Buy | ||
| Hercules Capital | HTGC | UBS | Neutral » Buy | $18.50 | |
| Duolingo | DUOL | Evercore ISI | In-line » Outperform | $210 | |
| Columbia Banking | COLB | DA Davidson | Neutral » Buy | $36 | |
| Capricor Therapeutics | CAPR | Piper Sandler | Neutral » Overweight | $25 | |
| Akamai Tech | AKAM | Piper Sandler | Neutral » Overweight | $125 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Xenia Hotels | XHR | BMO Capital Markets | Outperform » Market Perform | $20.50 | |
| PG&E | PCG | BofA Securities | Buy » Neutral | $13 | |
| Myriad Genetics | MYGN | Piper Sandler | Overweight » Underweight | $2 | |
| Miami International Holdings | MIAX | Morgan Stanley | Overweight » Equal-Weight | $50 | |
| LexinFintech | LX | Citigroup | Buy » Neutral | $1.20 | |
| Edison | EIX | BofA Securities | Buy » Neutral | $51 | |
| Barclays PLC | BCS | BofA Securities | Buy » Neutral | ||
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Beyond Air | XAIR | Lake Street | Buy | $10 | |
| Uber | UBER | Rosenblatt | Buy | $100 | |
| 10x Genomics | TXG | RBC Capital Mkts | Sector Perform | $70 | |
| Revvity | RVTY | RBC Capital Mkts | Sector Perform | $135 | |
| Red Violet | RDVT | Needham | Buy | $90 | |
| Raymond James | RJF | Truist | Hold | $188 | |
| Perpetua Resources | PPTA | Scotiabank | Sector Outperform | ||
| Patrick Industries | PATK | Northcoast | Buy | $121 | |
| Mobility Global | MBGL | Barclays | Equal Weight | $23 | |
| Mettler-Toledo | MTD | RBC Capital Mkts | Sector Perform | $1515 | |
| Lyft | LYFT | Rosenblatt | Neutral | ||
| Lumentum | LITE | Deutsche Bank | Buy | $1200 | |
| LPL Financial | LPLA | Truist | Hold | $389 | |
| Latigo Biotherapeutics | LTGO | Goldman | Buy | $73 | |
| Latigo Biotherapeutics | LTGO | Guggenheim | Buy | $50 | |
| Latigo Biotherapeutics | LTGO | Leerink Partners | Outperform | $36 | |
| Latigo Biotherapeutics | LTGO | Jefferies | Buy | $50 | |
| Instacart | CART | Rosenblatt | Neutral | $55 | |
| Ingram Micro Holding Corp. | INGM | Deutsche Bank | Hold | $30 | |
| Hewlett Packard Enterprise | HPE | Deutsche Bank | Buy | $62 | |
| Gates Industrial | GTES | DA Davidson | Neutral | $29 | |
| Expedia Group | EXPE | Rosenblatt | Neutral | $360 | |
| eToro Group Ltd | ETOR | KeyBanc Capital Markets | Overweight | $45 | |
| Dell | DELL | Deutsche Bank | Hold | $480 | |
| DoorDash | DASH | Rosenblatt | Buy | $270 | |
| Coherent | COHR | Deutsche Bank | Buy | $400 | |
| Cisco | CSCO | Deutsche Bank | Buy | $135 | |
| Booking Holdings | BKNG | Rosenblatt | Buy | $245 | |
| BlossomHill Therapeutics | BLSM | JP Morgan | Overweight | $28 | |
| BlossomHill Therapeutics | BLSM | H.C. Wainwright | Buy | $35 | |
| BlossomHill Therapeutics | BLSM | Guggenheim | Buy | $30 | |
| Assembly Biosciences | ASMB | UBS | Buy | $52 | |
| Arista Networks | ANET | Deutsche Bank | Buy | $220 | |
| Airbnb | ABNB | Rosenblatt | Buy | $220 | |
| Aclaris Therapeutics | ACRS | Canaccord Genuity | Buy | $10 | |
| A10 Networks | ATEN | Deutsche Bank | Hold | $28 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Element Solutions | ESI | BofA Securities | Buy | $42 | |
| Interactive Brokers | IBKR | UBS | Neutral | $102 | |
| BorgWarner | BWA | RBC Capital Mkts | Outperform | $87 | |
| Rocket Pharmaceuticals | RCKT | Chardan Capital Markets | Buy | $11 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |